Hervé Pouzoullic

Find him on :

Specialization

Hervé is the Founder and CEO of Vim Vitae Consulting, bringing 30+ years of executive experience in building and scaling commercial operations for life sciences companies. His career uniquely combines deep operational expertise with corporate finance mastery, including M&A, divestitures, integrations, and turnarounds across both multinational corporations and start-ups.

He has driven over $400M in commercial success across EMEA, Asia-Pacific, and North America, with full P&L responsibility for businesses valued at $120M in publicly listed companies. At Thermo Fisher Scientific, Hervé pioneered the mRNA business from zero to $700M, establishing strategic partnerships with BioNTech and CureVac that positioned the company for breakthrough growth during COVID-19.

As a former General Manager with Finance Director credentials (KPMG), Hervé brings rare dual expertise: the strategic vision to identify transformative opportunities and the operational discipline to execute complex commercial builds, integrations, and market entries.

Key expertise areas

Notable engagements

Built Thermo Fisher’s mRNA business from $0 to $700M+ in seven years with partnerships across 50+ companies.
Led $120M P&L turnaround at Life Technologies France.
Established commercial organizations for SeqOne Genomics (bioinformatics).
Currently developing go-to-market strategies for biotech scale-ups including Rarecells (circulating tumor cells), Cytosurge (single cell gene editing), and Eukarÿs (bioproduction).

Markets

Europe, North America, Asia-Pacific.

Academic background

INSEAD/CEDEP International General Management Program, Sciences-Po Paris (Master’s in Economics – Finance & Marketing), Paris Dauphine University (Master’s in Finance).

Our team